Both non-small lung cancer and small cell lung cancer is a disease that now has various therapeutic options available, according to experts. Lung cancer is a disease that now has various therapeutic ...

Lung cancer is the leading cause of cancer-related mortality worldwide, with significant heterogeneity among its major histological subtypes: adenocarcinoma (ADC), squamous cell carcinoma (SCC), and ...

A targeted therapy called sevabertinib has been approved for patients with non-small cell lung cancer that carries an activating mutation in the HER2 gene.

Fine particulate matter PM2.5 increases the risk of all subtypes of lung cancer, while NO2, O3 and SO2 are linked to non-small-cell lung cancer “We used national air quality data combined with ...

New targeted drugs transform HER2, ROS1 and ALK lung cancer care, boosting brain response and survival—while precision choices still matter.

Shira Boehler shares her journey being diagnosed with Stage 1 lung cancer. A doctor explains the need for better lung cancer screening for asymptomatic, never smokers.

University of Pennsylvania Perelman School of Medicine and Yale University School of Medicine, along with other collaborators, report that lung adenocarcinoma can engage nerve pathways that link the ...

Led by Dr. Mao Mao and a multidisciplinary team from leading Chinese hospitals, the multicenter retrospective study enrolled 1,814 participants, including 1,095 lung cancer patients. Blood samples ...

Lung cancer traditionally presents itself when associated with cigarette smoking, but now lung cancer is increasingly being diagnosed in people who have never smoked a day in their lives. This ...